Placeholder Banner

BIO Joins Alliance to Protect Medical Innovation

October 4, 2018

BIO Joins Alliance to Protect Medical Innovation

Biotechnology Innovation Organization (BIO) Director of Communications Brian Newell released the following statement:

“BIO has joined the Alliance to Protect Medical Innovation. Small company innovators are at the center of the biopharmaceutical industry, and they will be disproportionately impacted by the flawed policies often touted as the way to lower the cost of prescription drugs. Innovation and bad public policy cannot coexist. That’s an important message often neglected in the debate about health care costs, and that’s precisely the message this organization will help deliver.”

Discover More
Washington, D.C. (October 3, 2022) – Today, a coalition of leading food and agriculture industry stakeholders in both Mexico and the United States released a new study revealing the broad impacts of Mexico’s proposed ban on biotech corn. The report,…
Biotechnology Industry Organization (BIO) President and CEO, Dr. Michelle McMurry-Heath, released the following statement following the announcement that Congress reached an agreement on the Prescription Drug User Fee Act (PDUFA): “For 30…
Dr. Michelle McMurry-Heath, president & CEO of the Biotechnology Innovation Organization, released the following statement in response to the Biden Administration’s “Advancing Biotechnology and Biomanufacturing” Executive Order: “BIO welcomes…